These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 8138660)

  • 1. Breast Cancer Recurrence Risk Assessment: Is Non-Invasive Monitoring an Option?
    Schunkert EM; Zhao W; Zänker K
    Biomed Hub; 2018; 3(3):1-17. PubMed ID: 31988964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.
    Tampellini M; Berruti A; Gerbino A; Buniva T; Torta M; Gorzegno G; Faggiuolo R; Cannone R; Farris A; Destefanis M; Moro G; Deltetto F; Dogliotti L
    Br J Cancer; 1997; 75(5):698-702. PubMed ID: 9043027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA.
    Sölétormos G; Nielsen D; Schiøler V; Skovsgaard T; Winkel P; Mouridsen HT; Dombernowsky P
    Ann Oncol; 1993 Dec; 4(10):861-9. PubMed ID: 8117606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between CEA, TPA, CA 15/3 and hydroxyproline, alkaline phosphatase, whole body retention of 99mTc MDP in the follow-up of bone metastases in breast cancer.
    Francini G; Montagnani M; Petrioli R; Paffetti P; Marsili S; Leone V
    Int J Biol Markers; 1990; 5(2):65-72. PubMed ID: 2283479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease.
    Pecherstorfer M; Zimmer-Roth I; Schilling T; Woitge HW; Schmidt H; Baumgartner G; Thiébaud D; Ludwig H; Seibel MJ
    J Clin Endocrinol Metab; 1995 Jan; 80(1):97-103. PubMed ID: 7829646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma.
    Francini G; Petrioli R; Gonnelli S; Correale P; Pozzessere D; Marsili S; Montagnani A; Lucani B; Rossi S; Monaco R; Manganelli A; Salvestrini F; Fiaschi AI
    Cancer; 2001 Sep; 92(6):1468-74. PubMed ID: 11745224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tumor markers for detection of bone metastasis in breast cancer patients.
    Aydiner A; Topuz E; Dişçi R; Yasasever V; Dinçer M; Dinçol K; Bilge N
    Acta Oncol; 1994; 33(2):181-6. PubMed ID: 8204273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can bone markers guide more effective treatment of bone metastases from breast cancer?
    Clemons M; Cole DE; Gainford MC
    Breast Cancer Res Treat; 2006 May; 97(1):81-90. PubMed ID: 16319976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of bone turnover in bone metastases.
    Fontana A; Delmas PD
    Cancer; 2000 Jun; 88(12 Suppl):2952-60. PubMed ID: 10898339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of clinical studies of CA 27.29 in breast cancer management.
    Beveridge RA
    Int J Biol Markers; 1999; 14(1):36-9. PubMed ID: 10367248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA 15.3 with urinary calcium excretion is useful in the diagnosis and monitoring of bone metastases from breast cancer.
    Yadav GC; Rao A; Motawy MM; Safadi N; Ahmed MJ
    Int J Biol Markers; 1993; 8(4):208-14. PubMed ID: 8138660
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.